LENSAR Inc
NASDAQ:LNSR

  • LAST PRICE
    7.5300
  • TODAY'S CHANGE (%)
    -0.1600 (-2.0806%)
  • Bid / Lots
    7.0000/ 1
  • Ask / Lots
    9.5000/ 1
  • Open / Previous Close
    7.8200 / 7.6900
  • Day Range
    7.4000
    7.8200
  • 52 Week Range
    2.1200
    8.1700
  • Volume
    31,449

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 26, 2024

      Show headlines and story abstract

    • 8:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
      Companies Mentioned: LNSR

      LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

      ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer, will participate in a fireside chat at the BTIG 4th Annual Ophthalmology Day on Monday, December 2, 2024 at 2 p.m. ET. Additionally, LENSAR management will host 1-on-1 meetings with institutional investors.

  • Nov 7, 2024

      Show headlines and story abstract

    • 7:07AM ET on Thursday Nov 07, 2024 by MT Newswires
      Companies Mentioned: LNSR
      07:07 AM EST, 11/07/2024 (MT Newswires) -- ...

    • 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: LNSR
      Other income, net 153 265 511 465 ------ ------ ------- ------- Net (loss) income (1,502) 2,568 (12,702) (10,457) ------ ------ ------- ------- Other comprehensive (loss) income Change in unrealized gain on investments 21 -- 11 -- Net (loss) income and comprehensive (loss) income $(1,481) $ 2,568 $(12,691) $(10,457) ====== ====== ======= ======= Net (loss) earnings per common share: Basic $ (0.13) $ 0.13 $ (1.11) $ (0.96) ====== ====== ======= ======= Diluted $ (0.13) $ (0.23) $ (1.11) $ (0.96) ====== ====== ======= ======= Weighted-average number of common shares used in calculation of net (loss) earnings per share: Basic 11,604 11,102 11,481 10,881 ====== ====== ======= ======= Diluted 11,604 11,956 11,481 10,881 ====== ====== ======= ======= LENSAR, Inc. BALANCE SHEETS (In thousands, except per share amounts) September 30, 2024 December 31, 2023 -------------------- --------------------- Assets Current assets: Cash and cash equivalents $ 10,442 $ 20,621 Short-term investments 7,638 3,443 Accounts receivable, net of allowance of $39 and $62, respectively 4,373 4,001 Notes receivable, net of allowance of $7 and $7, respectively 352 323 Inventories 14,892 15,689 Prepaid and other current assets 1,705 2,367 --------------- -------------- Total current assets 39,402 46,444 Property and equipment, net 677 679 Equipment under lease, net 12,303 7,459 Long-term investments 494 492 Notes and other receivables, long-term, net of allowance of $20 and $26, respectively 952 1,279 Intangible assets, net 6,344 11,025 Other assets 1,847 2,207 Total assets $ 62,019 $ 69,585 =============== ============== Liabilities, redeemable convertible preferred stock, and stockholders' equity Current liabilities: Accounts payable $ 3,867 $ 4,007 Accrued liabilities 5,800 5,717 Deferred revenue 1,437 1,349 Operating lease liabilities 574 559 --------------- -------------- Total current liabilities 11,678 11,632 Long-term operating lease liabilities 1,319 1,750 Warrant liabilities 12,295 8,457 Other long-term liabilities 205 570 Total liabilities 25,497 22,409 --------------- -------------- Series A Redeemable Convertible Preferred Stock, par value $0.01 per share, 20 shares authorized at September 30, 2024 and December 31, 2023; 20 shares issued and outstanding at September 30, 2024 and December 31, 2023; aggregate liquidation preference of $20,000 at September 30, 2024 and December 31, 2023 13,784 13,747 Stockholders' equity: Preferred stock, par value $0.01 per share, 9,980 shares authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023 -- -- Common stock, par value $0.01 per share, 150,000 shares authorized at September 30, 2024 and December 31, 2023; 11,612 and 11,327 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 116 113 Additional paid-in capital 147,200 145,203 Accumulated other comprehensive income 15 4 Accumulated deficit (124,593) (111,891) --------------- -------------- Total stockholders' equity 22,738 33,429 Total liabilities, redeemable convertible preferred stock, and stockholders' equity $ 62,019 $ 69,585 =============== ==============

    • 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: LNSR
      Other income, net 153 265 511 465 ------ ------ ------- ------- Net (loss) income (1,502) 2,568 (12,702) (10,457) ------ ------ ------- ------- Other comprehensive (loss) income Change in unrealized gain on investments 21 -- 11 -- Net (loss) income and comprehensive (loss) income $(1,481) $ 2,568 $(12,691) $(10,457) ====== ====== ======= ======= Net (loss) earnings per common share: Basic $ (0.13) $ 0.13 $ (1.11) $ (0.96) ====== ====== ======= ======= Diluted $ (0.13) $ (0.23) $ (1.11) $ (0.96) ====== ====== ======= ======= Weighted-average number of common shares used in calculation of net (loss) earnings per share: Basic 11,604 11,102 11,481 10,881 ====== ====== ======= ======= Diluted 11,604 11,956 11,481 10,881 ====== ====== ======= ======= LENSAR, Inc. BALANCE SHEETS (In thousands, except per share amounts) September 30, 2024 December 31, 2023 -------------------- --------------------- Assets Current assets: Cash and cash equivalents $ 10,442 $ 20,621 Short-term investments 7,638 3,443 Accounts receivable, net of allowance of $39 and $62, respectively 4,373 4,001 Notes receivable, net of allowance of $7 and $7, respectively 352 323 Inventories 14,892 15,689 Prepaid and other current assets 1,705 2,367 --------------- -------------- Total current assets 39,402 46,444 Property and equipment, net 677 679 Equipment under lease, net 12,303 7,459 Long-term investments 494 492 Notes and other receivables, long-term, net of allowance of $20 and $26, respectively 952 1,279 Intangible assets, net 6,344 11,025 Other assets 1,847 2,207 Total assets $ 62,019 $ 69,585 =============== ============== Liabilities, redeemable convertible preferred stock, and stockholders' equity Current liabilities: Accounts payable $ 3,867 $ 4,007 Accrued liabilities 5,800 5,717 Deferred revenue 1,437 1,349 Operating lease liabilities 574 559 --------------- -------------- Total current liabilities 11,678 11,632 Long-term operating lease liabilities 1,319 1,750 Warrant liabilities 12,295 8,457 Other long-term liabilities 205 570 Total liabilities 25,497 22,409 --------------- -------------- Series A Redeemable Convertible Preferred Stock, par value $0.01 per share, 20 shares authorized at September 30, 2024 and December 31, 2023; 20 shares issued and outstanding at September 30, 2024 and December 31, 2023; aggregate liquidation preference of $20,000 at September 30, 2024 and December 31, 2023 13,784 13,747 Stockholders' equity: Preferred stock, par value $0.01 per share, 9,980 shares authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023 -- -- Common stock, par value $0.01 per share, 150,000 shares authorized at September 30, 2024 and December 31, 2023; 11,612 and 11,327 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 116 113 Additional paid-in capital 147,200 145,203 Accumulated other comprehensive income 15 4 Accumulated deficit (124,593) (111,891) --------------- -------------- Total stockholders' equity 22,738 33,429 Total liabilities, redeemable convertible preferred stock, and stockholders' equity $ 62,019 $ 69,585 =============== ==============

  • Nov 1, 2024

      Show headlines and story abstract

    • 6:32PM ET on Friday Nov 01, 2024 by Dow Jones
      Companies Mentioned: LNSR

      LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted two newly-hired non-executive employees stock options to purchase an aggregate of 650 shares of the Company's common stock. The options were granted as of November 1, 2024, as inducements material to each employee entering into employment with the Company. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

Peers Headlines